TOTakehito Otsubo

Takehito Otsubo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takehito Otsubo has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term outcomes of endoscopic transpapillary gallbladder drainage using a novel spiral plastic stent in acute calculus cholecystitis

    by Junya Sato, Kazunari Nakahara, Yosuke Michikawa, Keigo Suetani, Yosuke Igarashi, Akihiro Sekine, Yusuke Satta, Shinjiro Kobayashi, Takehito Otsubo, Keisuke Tateishi

    Background: Endoscopic transpapillary gallbladder stenting (EGBS) is considered for patients with contraindications to early surgery for acute calculus cholecystitis. However, evidence regarding the long-term outcomes of EGBS is insufficient to date. The aim of the study was to evaluate the feasibility of EGBS as a bridge to or alternative to surgery when there are contraindications. Methods: We reviewed the cases of patients who underwent EGBS using a novel spiral-shaped plastic stent for acute calculus cholecystitis between January 2011 and December 2019. We retrospectively evaluated the long-term outcomes of EGBS using a novel spiral-shaped plastic stent. Results: Forty-nine patients were included. The clinical success rate of EGBS was 97%. After EGBS, 25 patients (surgery group) underwent elective cholecystectomy and 24 patients did not (follow-up group). In the surgery group, the median period from EGBS to surgery was 93 days. There was a single late adverse event with cholecystitis recurrence. In the follow-up group, the median follow-up period was 236 days. Late adverse events were observed in eight patients, including recurrence of cholecystitis (four patients), duodenal penetration by the distal stent end (two patients), and distal stent migration (two patient). In the follow-up group, the time to recurrence of biliary obstruction was 527 days. Conclusions: EGBS with a novel spiral-shaped plastic stent is safe and effective for long-term acute calculus cholecystitis. There is a possibility of EGBS to be a bridge to surgery and a surgical alternative for acute calculus cholecystitis in patients with contraindications to early cholecystectomy.


  • A nationwide certification system to increase the safety of highly advanced hepatobiliary‐pancreatic surgery

    by Takehito Otsubo, Shinjiro Kobayashi, Keiji Sano, Takeyuki Misawa, Satoshi Katagiri, Hisashi Nakayama, Shuji Suzuki, Manabu Watanabe, Shunichi Ariizumi, Michiaki Unno, et al.

    Background: To ensure that highly advanced hepatobiliary‐pancreatic surgery (HBPS) is performed safely, the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS) board certification system for expert surgeons established a safety committee to monitor surgical safety.Methods: We investigated postoperative mortality rates based on summary reports of numbers and outcomes of highly advanced HBPS submitted annually by the board‐certified training institutions from 2012 to 2019. We also analyzed summary reports on mortality cases submitted by institutions with high 90‐day post‐HBPS mortality rates and recommended site visits and surveys as necessary.Results: Highly advanced HBPS was performed in 121 518 patients during the 8‐year period. Thirty‐day mortality rates from 2012 to 2019 were 0.92%, 0.8%, 0.61%, 0.63%, 0.70%, 0.59%, 0.48%, and 0.52%, respectively (P < .001). Ninety‐day mortality rates were 2.1%, 1.82%, 1.62%, 1.28%, 1.46%, 1.22%, 1.19%, and 0.98%, respectively (P < .001). Summary reports were submitted by 20 hospitals between 2015 and 2019. Mortality rates before and after the start of report submission and audit were 5.72% and 2.79%, respectively (odds ratio 0.690, 95% confidence interval 0.487‐0.977; P = .037).Conclusions: Development of a system for designation of board‐certified expert surgeons and safety management improved the mortality rate associated with highly advanced HBPS.


  • Open Access

    Giant Adrenal Lipoma with Hemorrhage Requiring Extended Surgical Resection

    by Kanji Otsubo, Shinjiro Kobayashi, Keisuke Ida, Masafumi Katayama, Satoshi Koizumi, Junki Koike, Takehito Otsubo, Atsuhito Tsuchihashi

    Adrenal lipoma is a rare, benign tumor, reported to account for 0.7% of primary adrenal tumors. A 69-year-old man presented with left lateral abdominal pain. Computed tomography (CT) was performed, and a huge, irregularly shaped retroperitoneal tumor of uneven internal density was identified, with the border between the tumor and the pancreas and kidney being unclear. Active hemorrhage was also depicted. The tumor consisted mainly of fat, with the exception of the hematoma; it measured 200 mm; and the boundary between it and nearby organs, such as the pancreas, was unclear. Despite angiography being performed twice, the responsible vessel was not identified. Thus, for the purpose of both diagnosis and treatment, we resected the tumor, and considering the possibility of a malignancy, such as liposarcoma, we also resected the pancreatic body and tail and the spleen. The final histopathologic diagnosis was benign adrenal lipoma with hemorrhage, with no invasion to surrounding tissue. Hemorrhage within an adrenal tumor is rare. Most adrenal lipomas are small “incidentalomas” and asymptomatic. With development of a large adrenal lipoma comes the possibility of hemorrhage along with the possibility of features suggestive of malignancy. We encountered a giant adrenal lipoma with hemorrhage and, because of the aforementioned features, performed extended surgical resection, seen in retrospect as oversurgery. The widespread use of CT has led to an increased number of reported cases of adrenal lipoma. We anticipate an accumulation of case reports, which will allow for development of an appropriate treatment algorithm.


  • Open Access

    Difficult preoperative diagnosis of pancreatic hamartoma

    by Atsuhito Tsuchihashi, Shinjiro Kobayashi, Junichi Tsuchiya, Masafumi Katayama, Satoshi Koizumi, Yasushi Ariizumi, Takehito Otsubo

    症例は65歳の女性.近医にて肝嚢胞の経過観察中に膵頭部に造影効果を伴う充実性腫瘍を指摘され当院へ紹介された.血液検査で各種ホルモン値の上昇は認めず,腹部造影CT検査で膵頭部に15mmの境界明瞭な類円形の腫瘤を認めた.動脈相で不均一に低から等吸収,門脈相から遅延相にかけて均一な強い造影効果を示した.EUS-FNAで病理組織学的診断はつかなかった.画像診断にて非機能性膵神経内分泌腫瘍を疑い幽門輪温存膵頭十二指腸切除術を行った.膵頭部に境界明瞭な結節性病変を認めた.病理組織所見で線維化を背景に膵管,腺房組織増生と小膵管弾性板,末梢神経細胞,ランゲルハンス島の消失を認め膵過誤腫と診断した.膵過誤腫は報告例が41例と稀な疾患である事に加え,術前組織診断を得る事は非常に困難である.術前に非機能性膵神経内分泌腫瘍との鑑別に難渋した膵過誤腫の1例を経験したので報告する.


  • Mixed acinar-endocrine carcinoma of the pancreas with intraductal growth into the main pancreatic duct: Report of a case

    by Shinjiro Kobayashi, Takeshi Asakura, Nobuyuki Ohike, Takeharu Enomoto, Joe Sakurai, Satoshi Koizumi, Taiji Watanabe, Hiroshi Nakano, Takehito Otsubo

    The patient was a 75-year-old asymptomatic man, in whom a tumor mass in the pancreatic tail had been found 6 months earlier. Computed tomography revealed a mass 7 cm in diameter, and an enhancement with contrast medium was observed at the periphery and partially inside the mass, but not in most parts of the tumor. Endoscopic retrograde cholangiopancreatography showed a filling defect in the main pancreatic duct. A distal pancreatectomy was performed because of the possibility of a malignant tumor. The tumor consisted of a lobular invasive growth component and a component with intraductal growth into the main pancreatic duct, and histologically the tumor cells had solid acinar to partially trabecular/tubular patterns. Trypsin (an acinic cell marker) expression was widely observed, followed by the expression of chromogranin A (an endocrine cell marker) in about 30% of the tumor cells. The tumor was diagnosed as mixed acinar-endocrine carcinoma according to the WHO classification.


  • Open Access

    Putative tumor suppressor EDD interacts with and up‐regulates APC

    by Ryuichi Ohshima, Tomohiko Ohta, Wenwen Wu, Ayaka Koike, Tsuguo Iwatani, Michelle Henderson, Colin K. W. Watts, Takehito Otsubo

    Adenomatous polyposis coli (APC), whose mutation causes colorectal cancers, is a key player in the Wnt signaling pathway. While the role of APC in inhibition of β‐catenin/LEF1‐dependent activation of transformation‐inducing genes has been intensively studied and well established, regulation of APC expression at the protein level is only partially understood. Here we report that APC is up‐regulated by EDD, the mammalian orthologue of Drosophila melanogaster“hyperplastic discs” gene (hyd) that is considered to be a putative tumor suppressor. Screening of APC immunocomplexes by mass spectrometry identified EDD as a putative APC‐interacting protein. Exogenously expressed and endogenous APC interacted with EDD in vivo. Indirect immunofluorescent analyses demonstrated that APC and EDD co‐localized in the cytoplasm of the cell. Over‐expression of EDD enhanced the protein expression level of APC and its binding partner Axin, resulting in inhibition of Wnt signaling downstream of β‐catenin. Conversely, siRNA knock‐down of EDD down‐regulated APC at the protein level without altering its mRNA level, causing enhanced protein expression of β‐catenin. Thus, through protein–protein interaction, EDD stabilizes APC and up‐regulates APC's function to inhibit β‐catenin, suggesting that EDD could act as a colorectal tumor suppressor.